This bill mandates that hospitals, ambulatory surgical centers, and emergency medical care centers develop and implement a comprehensive screening and treatment plan for venous thromboembolism (VTE). Specifically, it requires these facilities to create policies that include assessing patients for VTE risk using recognized tools and providing treatment options for diagnosed patients. Additionally, all nonphysician personnel must receive annual training on these policies. The bill also introduces a new section to RSA 141-B, establishing a statewide VTE registry, which the Department of Health and Human Services will maintain through a contract with a qualified private entity.

The private entity responsible for the registry must meet specific criteria, including being a not-for-profit organization with at least 15 years of experience in blood clot prevention and treatment. Starting July 1, 2027, healthcare facilities will be required to report data on VTE cases to the registry, including patient demographics and treatment details. The Department will compile this data and submit a report to state leadership by November 1, 2027, analyzing VTE incidence and outcomes. The bill emphasizes the importance of using this data for medical research and education to improve patient care and reduce VTE-related morbidity and mortality. The act will take effect 60 days after passage.